# Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD

> **NCT03150667** · PHASE4 · UNKNOWN · sponsor: **North Texas Veterans Healthcare System** · enrollment: 220 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT03150667
- **Lead sponsor:** North Texas Veterans Healthcare System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-10
- **Primary completion:** 2019-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2018-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03150667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03150667, "Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03150667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*